Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
IsraelUnknownPHASE1
Conditions
Androgenic Alopecia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Rabin Medical Center, Petah Tikva, Israel
Contact: Study coordinator (Helena Martinez, MD)Sheba Medical Center, Ramat Gan, Israel
Contact: Study coordinator (Anna Lyakhovitsky, MD)Sourasky Medical Center, Tel Aviv, Israel
Contact: Study coordinator (Amir Koren)
Study leads
Solli Brawer
Study Director
Follicle Pharma Ltd